摘要 |
The present invention discloses a method for evaluating the allergen sensitivity of an individual and/or the clinical efficacy of an allergen immunotherapy comprising the steps: providing at least two samples selected from the group consisting of blood or fractions thereof, connective tissue, nasal, bronchial, skin or gut biopsy material from an individual subjected or intended to be subjected to an immunotherapy with at least one pure allergen or derivative thereof, wherein the samples contain cells capable of releasing mediators in response to said allergen, contacting said sample with said allergen or derivative thereof, and determining the amounts of mediators released from said sample and evaluating the allergen sensitivity of the individual prior to therapy and/or the clinical efficacy of the immunotherapy by comparing said amounts. |
申请人 |
BIOMAY AG;PUROHIT, ASHOK;METZ-FAVRE, CARINE;VEROT, ANGELE;PAULI, GABRIELLE;LAFFER, SYLVIA;VALENTA, RUDOLF;MOTHES-LUKSCH, NADINE;VALENT, PETER |
发明人 |
PUROHIT, ASHOK;METZ-FAVRE, CARINE;VEROT, ANGELE;PAULI, GABRIELLE;LAFFER, SYLVIA;VALENTA, RUDOLF;MOTHES-LUKSCH, NADINE;VALENT, PETER |